UBS Group’s IN8bio INAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Buy |
479
+68
| +17% | +$142 | ﹤0.01% | 8365 |
|
|
2025
Q1 | $2.05K | Sell |
411
-1,551
| -79% | -$7.72K | ﹤0.01% | 8090 |
|
|
2024
Q4 | $15.1K | Buy |
1,962
+1,086
| +124% | +$8.37K | ﹤0.01% | 6823 |
|
|
2024
Q3 | $7.09K | Buy |
+876
| New | +$7.09K | ﹤0.01% | 6728 |
|
|
2024
Q1 | – | Sell |
-150
| Closed | -$6.22K | – | 8359 |
|
|
2023
Q4 | $6.22K | Sell |
150
-16
| -10% | -$663 | ﹤0.01% | 6511 |
|
|
2023
Q3 | $5.17K | Buy |
+166
| New | +$5.17K | ﹤0.01% | 6247 |
|
|
2023
Q2 | – | Sell |
-104
| Closed | -$4.07K | – | 8081 |
|
|
2023
Q1 | $4.07K | Sell |
104
-11
| -10% | -$431 | ﹤0.01% | 7140 |
|
|
2022
Q4 | $7.99K | Sell |
115
-176
| -60% | -$12.2K | ﹤0.01% | 7639 |
|
|
2022
Q3 | $18K | Buy |
291
+157
| +117% | +$9.71K | ﹤0.01% | 6430 |
|
|
2022
Q2 | $9K | Buy |
134
+6
| +5% | +$403 | ﹤0.01% | 7100 |
|
|
2022
Q1 | $13K | Buy |
128
+70
| +121% | +$7.11K | ﹤0.01% | 7004 |
|
|
2021
Q4 | $8K | Sell |
58
-57
| -50% | -$7.86K | ﹤0.01% | 7913 |
|
|
2021
Q3 | $24K | Buy |
+115
| New | +$24K | ﹤0.01% | 5838 |
|